According to the National Comprehensive Cancer Network (NCCN) guidelines, patients diagnosed with low-risk PCa with the GS ≤6, T1-T2a and PSA<10ng/ml require active surveillance (AS) or radical prostatectomy (RP). Here, KLK3 is linked to posterior cortical atrophy.